KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year book value per share growth
Latest
-58.62%
↓ 3512% vs avg
Percentile
P5
Near historical low
Streak
1 qtr
Consecutive growthDecelerating
Average
-1.62%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -58.62% |
| Q3 2025 | -60.31% |
| Q2 2025 | -30.32% |
| Q1 2025 | -3.92% |
| Q4 2024 | -23.23% |
| Q3 2024 | -21.13% |
| Q2 2024 | 85.77% |
| Q1 2024 | -22.95% |
| Q4 2023 | -18.22% |
| Q3 2023 | -13.65% |
| Q2 2023 | -28.11% |
| Q1 2023 | 11.55% |
| Q4 2022 | -12.75% |
| Q3 2022 | -11.14% |
| Q2 2022 | -11.22% |
| Q1 2022 | -8.74% |
| Q4 2021 | -6.97% |
| Q3 2021 | -11.85% |
| Q2 2021 | 248.11% |
| Q1 2021 | -10.15% |
| Q4 2020 | -12.99% |
| Q3 2020 | -11.15% |
| Q2 2020 | -6.70% |
| Q1 2020 | -8.30% |
| Q4 2019 | -5.81% |
| Q3 2019 | 3.46% |
| Q2 2019 | -6.75% |
| Q1 2019 | -14.71% |
| Q4 2018 | 191.25% |
| Q3 2018 | -3.71% |
| Q2 2018 | -4.68% |
| Q1 2018 | -14.76% |
| Q4 2017 | 12.87% |
| Q3 2017 | -14.66% |
| Q2 2017 | -29.13% |
| Q1 2017 | -36.05% |
| Q3 2016 | -5.82% |
| Q2 2016 | -67.00% |
| Q1 2016 | -12.65% |
| Q4 2015 | -9.76% |